Long Term Follow-Up Study of the Safety and Exploratory Efficacy of Pneumostem in Premature Infants With Bronchopulmonary Dysplasia
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 26 May 2015
At a glance
- Drugs Mesenchymal stem cell therapy (Primary)
- Indications Bronchopulmonary dysplasia
- Focus Adverse reactions
- Sponsors Samsung Medical Center
- 19 May 2015 Planned End Date changed from 1 Dec 2013 to 1 Sep 2017 as reported by ClinicalTrials.gov record.
- 19 May 2015 Planned primary completion date changed from 1 Dec 2013 to 1 Sep 2017 as reported by ClinicalTrials.gov record.
- 24 Sep 2014 According to ClinicalTrials.gov, the recruitment status of this study is unknown because the information has not been verified recently (last verified July 2012)